查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589727

事後緊急避孕藥市場：按類型、類別、年齡層、分佈分類 - 全球預測 2025-2030

Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年事後緊急避孕藥市場價值為10.2億美元，預計2024年將達到10.8億美元，複合年成長率為6.49%，到2030年將達到15.8億美元。

事後緊急避孕藥(ECP) 是更廣泛的避孕藥市場中的重要部分，主要用於性交後預防意外懷孕。 ECP 包括荷爾蒙製劑，包括levonorgestrel和醋酸烏利司他，在性交後 72 至 120 小時內最有效。當主要避孕方法失敗時，ECP 可以充當安全網，在降低墮胎率方面發揮作用，這凸顯了 ECP 的必要性。 ECP 主要用於避孕失敗、無保護性行為和性侵犯的情況。最終用途範圍涵蓋不同的人口統計數據，主要針對已開發和發展中地區的育齡婦女。市場成長主要是由於認知度和可用性的提高，尤其是幾個地區的店面銷售。對婦女生殖健康和自主權的日益關注進一步推動了需求。然而，文化和宗教的反對、有關安全性和有效性的錯誤訊息以及某些地區的監管障礙對成長構成了挑戰。潛在的商機在於擴大宣傳宣傳活動和利用數位平台進行教育。與醫療保健提供者合作以確保明智的決策和廣泛的准入也可能提高市場滲透率。創新可以集中在改進配方以延長保存期限，並探索生物分解性的包裝以吸引具有環保意識的消費者。市場本質上對社會狀況和法律體系的趨勢很敏感，凸顯了適應性的必要性。儘管存在障礙，但越來越多的人接受緊急避孕作為全面計劃生育的一部分，這代表著一條充滿希望​​的業務成長之路。強調基於證據的教育和遊說支持性政策有助於緩解挑戰。該市場的動態性質強調了與消費者持續接觸和策略夥伴關係關係的重要性，以創造一個支持 ECP 接受和使用的環境。

主要市場統計
基準年[2023] 10.2億美元
預測年份 [2024] 10.8億美元
預測年份 [2030] 15.8億美元
複合年成長率（%） 6.49%

市場動態：快速發展的事後緊急避孕藥市場的關鍵市場洞察

供需的動態交互作用正在改變事後緊急避孕藥市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 美國因意外懷孕而收養的人數增加。
    • 政府努力促進避孕藥的使用
  • 市場限制因素
    • 效能問題、事後緊急避孕藥召回問題
  • 市場機會
    • 製造商加強研發和聯合宣傳宣傳活動
    • 透過線上管道輕鬆獲取
  • 市場挑戰
    • 服用事後緊急避孕藥可能產生的副作用

波特的五力：駕馭事後緊急避孕藥市場的策略工具

波特的五力框架是了解事後緊急避孕藥市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解事後緊急避孕藥市場的外部影響

外部宏觀環境因素對事後緊急避孕藥市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解事後緊急避孕藥市場競爭狀況

對事後緊急避孕藥市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣事後緊急避孕藥市場供應商的績效評估

FPNV 定位矩陣是評估事後緊急避孕藥市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃事後緊急避孕藥市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，事後緊急避孕藥市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 美國因意外懷孕而收養的收養呈上升趨勢
      • 政府努力促進避孕藥具的使用
    • 抑制因素
      • 事後緊急避孕藥功效和召回率問題
    • 機會
      • 加強製造商的研發和聯合宣傳活動
      • 透過線上管道輕鬆獲得
    • 任務
      • 服用事後緊急避孕藥可能產生的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章事後緊急避孕藥市場：依類型

  • 抗黃體素
  • 複方藥物
  • 黃體酮錠劑

第7章事後緊急避孕藥市場：依類別

  • 品牌
  • 非專利的

第8章事後緊急避孕藥市場：依年齡段

  • 15-24
  • 25-34
  • 35-44
  • 45歲以上

第9章事後緊急避孕藥市場經銷商

  • 離線
  • 線上

第10章美洲事後緊急避孕藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太事後緊急避孕藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲事後緊急避孕藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 美國政府簽署行政命令擴大避孕措施
    • Gedeon Richter 從 Consilient Health 收購口服避孕藥領域
    • 醫療保健Start-Ups獲得破產避孕藥具提供者的病患記錄
    • 事後避孕藥品牌可加快進入零售商的速度並使每包供應量增加一倍
    • Curae Pharma360 推出非處方事後緊急避孕藥，以促進公平、可靠地獲得藥物，並與 Direct Relief 合作，為服務不足的女性提供醫療保健。
    • Aurobindo Pharma 避孕藥已獲得美國FDA核准
    • Perrigo 旗下 HRA Pharma 向 FDA 提交第一個非處方避孕藥申請
    • Lupin 在美國推出非專利避孕藥 Melze 膠囊
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Curae Pharma360 Inc.
  • Foundation Consumer Healthcare, LLC
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Northstar Rx LLC
  • Perrigo Company plc
  • Pfizer, Inc.
  • Piramal Enterprises Ltd.
  • Rapha Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Viatris Inc.
  • Wockhardt USA LLC
  • Xiromed, LLC
Product Code: MRR-43798151BF31

The Emergency Contraceptive Pills Market was valued at USD 1.02 billion in 2023, expected to reach USD 1.08 billion in 2024, and is projected to grow at a CAGR of 6.49%, to USD 1.58 billion by 2030.

Emergency contraceptive pills (ECPs) represent a critical segment of the broader contraceptive market, primarily used post-coitus to prevent unintended pregnancies. The scope of ECPs encompasses hormonal formulations, including levonorgestrel and ulipristal acetate, which are most effective within 72 to 120 hours post-intercourse. The necessity for ECPs is underscored by their role in reducing abortion rates by serving as a safety net when primary contraceptive methods fail. They are predominantly applied in cases of contraceptive failure, unprotected intercourse, or sexual assault. The end-use scope extends across various demographics, predominantly targeting women of reproductive age in both developed and developing regions. Market growth is primarily driven by increased awareness and accessibility, particularly through over-the-counter availability in several regions. Rising focus on women's reproductive health and autonomy further fuels demand. However, growth is challenged by cultural and religious opposition, misinformation regarding safety and efficacy, and regulatory barriers in certain geographies. Potential opportunities lie in expanding awareness campaigns and leveraging digital platforms for education. Collaborations with healthcare providers to ensure informed decisions and broader access could also enhance market penetration. Innovations can focus on enhanced formulations offering extended efficacy windows, and research into biodegradable packaging to appeal to eco-conscious consumers. The market is inherently sensitive to social and legislative developments, highlighting the need for adaptability. Despite the barriers, the increasing acceptance of emergency contraception as part of comprehensive family planning presents a promising avenue for business growth. Emphasizing evidence-based education and lobbying for supportive policies could mitigate challenges. The market's dynamic nature underscores the importance of continuous consumer engagement and strategic partnerships to foster a supportive environment for ECP acceptance and use.

KEY MARKET STATISTICS
Base Year [2023] USD 1.02 billion
Estimated Year [2024] USD 1.08 billion
Forecast Year [2030] USD 1.58 billion
CAGR (%) 6.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Emergency Contraceptive Pills Market

The Emergency Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption owing to unintended pregnancies in the U.S.
    • Government initiatives to promote use of contraceptive pills
  • Market Restraints
    • Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
  • Market Opportunities
    • Increasing R&D and collaborative awareness campaigns by manufacturers
    • Easy availability through online channel
  • Market Challenges
    • Probable side effects associated with consuming emergency contraceptive pills

Porter's Five Forces: A Strategic Tool for Navigating the Emergency Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Emergency Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Emergency Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Emergency Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Emergency Contraceptive Pills Market

A detailed market share analysis in the Emergency Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Emergency Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Emergency Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Emergency Contraceptive Pills Market

A strategic analysis of the Emergency Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Emergency Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Curae Pharma360 Inc., Foundation Consumer Healthcare, LLC, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer, Inc., Piramal Enterprises Ltd., Rapha Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Viatris Inc., Wockhardt USA LLC, and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Emergency Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Antiprogestin, Combination Pills, and Progesterone Pills.
  • Based on Category, market is studied across Branded and Generic.
  • Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
  • Based on Distribution, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption owing to unintended pregnancies in the U.S.
      • 5.1.1.2. Government initiatives to promote use of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D and collaborative awareness campaigns by manufacturers
      • 5.1.3.2. Easy availability through online channel
    • 5.1.4. Challenges
      • 5.1.4.1. Probable side effects associated with consuming emergency contraceptive pills
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Emergency Contraceptive Pills Market, by Type

  • 6.1. Introduction
  • 6.2. Antiprogestin
  • 6.3. Combination Pills
  • 6.4. Progesterone Pills

7. Emergency Contraceptive Pills Market, by Category

  • 7.1. Introduction
  • 7.2. Branded
  • 7.3. Generic

8. Emergency Contraceptive Pills Market, by Age Group

  • 8.1. Introduction
  • 8.2. 15-24
  • 8.3. 25-34
  • 8.4. 35-44
  • 8.5. 45 and Above

9. Emergency Contraceptive Pills Market, by Distribution

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Emergency Contraceptive Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Emergency Contraceptive Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Emergency Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Government of the United States Signed an Executive Order Expanding Access to Birth Control
    • 13.3.2. Gedeon Richter Acquires Oral Contraceptive Range from Consilient Health
    • 13.3.3. Health-Care Startup Up Acquires Patient Records of Bankrupt Birth Control Provider
    • 13.3.4. Morning After Pill Brand Speeds Up Retail Access, Doubles Supply Per Pack
    • 13.3.5. Curae Pharma360 Launches OTC Emergency Contraception to Advance Equitable, Reliable Access to Medicines; Partners with Direct Relief to Reach Underserved Women
    • 13.3.6. Aurobindo Pharma Receives USFDA Nod for Contraceptives
    • 13.3.7. Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
    • 13.3.8. Lupin Launches Generic Contraceptive Drug Merzee Capsules in U.S.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Afaxys Pharma, LLC
  • 3. Amneal Pharmaceuticals, Inc.
  • 4. Apotex Inc.
  • 5. Aurobindo Pharma Limited
  • 6. Bayer AG
  • 7. Bionpharma Inc.
  • 8. Cipla Limited
  • 9. Combe Incorporated
  • 10. Curae Pharma360 Inc.
  • 11. Foundation Consumer Healthcare, LLC
  • 12. Gedeon Richter PLC
  • 13. Glenmark Pharmaceuticals Limited
  • 14. Julie Product Inc.
  • 15. Lupin Limited
  • 16. Mankind Pharma Ltd.
  • 17. Merck & Co., Inc.
  • 18. Northstar Rx LLC
  • 19. Perrigo Company plc
  • 20. Pfizer, Inc.
  • 21. Piramal Enterprises Ltd.
  • 22. Rapha Pharmaceuticals, Inc.
  • 23. Sun Pharmaceutical Industries Limited
  • 24. Syzygy Healthcare Solutions, LLC
  • 25. Viatris Inc.
  • 26. Wockhardt USA LLC
  • 27. Xiromed, LLC

LIST OF FIGURES

  • FIGURE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMERGENCY CONTRACEPTIVE PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ANTIPROGESTIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023